Evidence supporting the use of: Alpha-Linolenic Acid
For the health condition: Lupus

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Alpha-Linolenic Acid (ALA) is an omega-3 fatty acid found in plant sources such as flaxseed, chia seeds, and walnuts. Its use in supporting or treating lupus (systemic lupus erythematosus, SLE) has some scientific basis, though evidence is limited and not robust. The rationale stems from the anti-inflammatory properties of omega-3 fatty acids, which can modulate immune responses and inflammation—central features of lupus pathology.

Several small clinical trials and animal studies have explored the effect of omega-3 supplementation (including ALA or its longer-chain derivatives EPA and DHA) on lupus. Some studies suggest that omega-3 fatty acids may reduce disease activity, lower inflammatory markers, and improve lipid profiles in lupus patients. However, most clinical trials have used fish oil (EPA/DHA), and results with ALA specifically are sparse and less conclusive.

Guidelines from organizations such as the Lupus Foundation of America acknowledge the potential benefits of omega-3s but do not recommend ALA as a primary therapy due to insufficient high-quality evidence. The conversion of ALA to EPA/DHA in the body is inefficient, which may limit its therapeutic potential compared to direct EPA/DHA supplementation.

In summary, there is some scientific rationale and preliminary clinical evidence for using ALA and related omega-3s in lupus, but the quality and quantity of direct evidence supporting ALA itself are low. Thus, its use is not standard or strongly validated, resulting in a low to moderate evidence rating.

More about Alpha-Linolenic Acid
More about Lupus

Products containing Alpha-Linolenic Acid

We currently have no products on Vitabase that contain this ingredient.